Biomarkers of Metabolic Syndrome and Prediabetes

Assessing Salivary Biomarkers for Risk Stratification in Metabolic Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01086137

Enrollment

102

Registered

2010-03-12

Start date

2010-03-31

Completion date

2011-12-31

Last updated

2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypertension, Metabolic Syndrome, Prediabetes

Keywords

salivary biomarker, metabolic syndrome, prediabetes, diabetes hypertension

Brief summary

The purpose of this study is to investigate the feasibility of using salivary biomarkers to screen for complications of metabolic syndrome including prediabetes.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Between the ages of 18 and 65 years * Males and females will be included in this study * All ethnic backgrounds will be included in this study * Acceptable health based on interview and medical history * Ability to comply with requirements of the study * Ability and willingness to provide signed informed consent

Exclusion criteria

* Eating or drinking anything but water within 10 hours of sample collection * Autoimmune disease * Type 1 diabetes * Pregnancy (\< 6 weeks postpartum) * History of Sjorgren's Syndrome * Dental work within the last two weeks * Ongoing or active parasitic, fungal, viral or bacterial infection

Design outcomes

Primary

Measure	Time frame
Salivary Biomarker Levels	baseline

Countries

United States

Outcome results